RBMMMDA: predicting multiple types of disease-microRNA associations

[1]  J. Gu,et al.  Epigenetic analysis of microRNA genes in tumors from surgically resected lung cancer patients and association with survival , 2015, Molecular carcinogenesis.

[2]  J. Zhao,et al.  Breast Cancer: Epidemiology and Etiology , 2015, Cell Biochemistry and Biophysics.

[3]  Jia Wei,et al.  MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2 , 2015, Tumor Biology.

[4]  D. Pang,et al.  Decrease of Let-7f in Low-Dose Metronomic Paclitaxel Chemotherapy Contributed to Upregulation of Thrombospondin-1 in Breast Cancer , 2015, International journal of biological sciences.

[5]  N. Seki,et al.  Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C , 2014, Journal of Human Genetics.

[6]  M. He,et al.  Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A. , 2014, International journal of clinical and experimental pathology.

[7]  Cheng Liang,et al.  Mirsynergy: detecting synergistic miRNA regulatory modules by overlapping neighbourhood expansion , 2014, Bioinform..

[8]  Xing Chen,et al.  MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET. , 2014, Cancer letters.

[9]  Xiangyang Chu,et al.  A microRNA gene signature for identification of lung cancer. , 2014, Surgical oncology.

[10]  J Wang,et al.  Integrated bioinformatics analyses identify dysregulated miRNAs in lung cancer. , 2014, European review for medical and pharmacological sciences.

[11]  Vince D. Calhoun,et al.  Restricted Boltzmann machines for neuroimaging: An application in identifying intrinsic networks , 2014, NeuroImage.

[12]  N. Zhong,et al.  Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells , 2014, Tumor Biology.

[13]  Tao Wang,et al.  miR-143 Inhibits NSCLC Cell Growth and Metastasis by Targeting Limk1 , 2014, International journal of molecular sciences.

[14]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[15]  Hongxia Ma,et al.  Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. , 2014, Gene.

[16]  U. Gezer,et al.  Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy , 2014, Oncology letters.

[17]  Yang Peng,et al.  MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression , 2014, Bioscience reports.

[18]  Hsuan-Yu Chen,et al.  MicroRNA-133a Suppresses Multiple Oncogenic Membrane Receptors and Cell Invasion in Non-Small Cell Lung Carcinoma , 2014, PloS one.

[19]  Y. Sher,et al.  ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells , 2014, PloS one.

[20]  P. Meltzer,et al.  A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis , 2014, Oncogene.

[21]  G. Calin,et al.  Clinical relevance of circulating cell-free microRNAs in cancer , 2014, Nature Reviews Clinical Oncology.

[22]  Lin Jiang,et al.  Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer. , 2014, Gene.

[23]  Jianjun Wang,et al.  miR-27b targets LIMK1 to inhibit growth and invasion of NSCLC cells , 2014, Molecular and Cellular Biochemistry.

[24]  N. Yang,et al.  MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer. , 2013, Acta biochimica et biophysica Sinica.

[25]  Jan Gorodkin,et al.  Protein-driven inference of miRNA–disease associations , 2013, Bioinform..

[26]  Lijun Xu,et al.  Targeting PKCε by miR‐143 regulates cell apoptosis in lung cancer , 2013, FEBS letters.

[27]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[28]  D. Beer,et al.  Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma , 2013, Clinical Cancer Research.

[29]  Xia Li,et al.  Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes , 2013, BMC Systems Biology.

[30]  Yufei Huang,et al.  Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.

[31]  Yuhao Wang,et al.  Predicting drug-target interactions using restricted Boltzmann machines , 2013, Bioinform..

[32]  Y. Dang,et al.  Underexpression of miR-34a in Hepatocellular Carcinoma and Its Contribution towards Enhancement of Proliferating Inhibitory Effects of Agents Targeting c-MET , 2013, PloS one.

[33]  Ping Yang,et al.  Lung cancer in China: challenges and interventions. , 2013, Chest.

[34]  Xueru Mu,et al.  MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met. , 2013, International journal of oncology.

[35]  T. Sellers,et al.  Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer , 2013, Oncogene.

[36]  Jinyi Guo,et al.  The Heterochronic microRNA let-7 Inhibits Cell Motility by Regulating the Genes in the Actin Cytoskeleton Pathway in Breast Cancer , 2013, Molecular Cancer Research.

[37]  Hao Li,et al.  miR‐137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6 , 2013, FEBS letters.

[38]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[39]  Jianlin Cheng,et al.  Predicting protein residue-residue contacts using deep networks and boosting , 2012, Bioinform..

[40]  T. Allen,et al.  Lung cancer genotype-based therapy and predictive biomarkers: present and future. , 2012, Archives of pathology & laboratory medicine.

[41]  Hong Wang,et al.  MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R , 2012, PloS one.

[42]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.

[43]  Pei-ying Zhang,et al.  MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[44]  L. Chow,et al.  Aromatase inhibitor treatment of breast cancer cells increases the expression of let‐7f, a microRNA targeting CYP19A1 , 2012, The Journal of pathology.

[45]  K. Cianflone,et al.  Let-7b Inhibits Human Cancer Phenotype by Targeting Cytochrome P450 Epoxygenase 2J2 , 2012, PloS one.

[46]  J. Soh,et al.  Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. , 2012, Lung cancer.

[47]  A. Schetter,et al.  Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancer , 2012, International journal of cancer.

[48]  Zhaolei Zhang,et al.  Evidence for Positive Selection on a Number of MicroRNA Regulatory Interactions during Recent Human Evolution , 2012, PLoS genetics.

[49]  S. Clark,et al.  Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer , 2012, Oncogene.

[50]  Kevin Struhl,et al.  An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis , 2011, Cell.

[51]  Chaoqian Xu,et al.  The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 , 2011, Nature Medicine.

[52]  F. Yu,et al.  Plasma miR-221 as a Predictive Biomarker for Chemoresistance in Breast Cancer Patients who Previously Received Neoadjuvant Chemotherapy , 2011, Oncology Research and Treatment.

[53]  M. Esteller.  Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[54]  N. Seki,et al.  Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma , 2011, Journal of Human Genetics.

[55]  Sheng Tan,et al.  Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. , 2011, Cancer research.

[56]  Yun Xiao,et al.  Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.

[57]  G. Calin,et al.  Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome. , 2011, Blood.

[58]  S. Xiong,et al.  MicroRNA-7 Inhibits the Growth of Human Non-Small Cell Lung Cancer A549 Cells through Targeting BCL-2 , 2011, International journal of biological sciences.

[59]  Donglei Liu,et al.  MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2 , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[60]  Zhaoli Chen,et al.  DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer , 2011, Cancer biology & therapy.

[61]  Eric Lai,et al.  MicroRNA-Related Cofilin Abnormality in Alzheimer's Disease , 2010, PloS one.

[62]  Ya‐Wen Cheng,et al.  Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. , 2010, Cancer research.

[63]  Yun Xiao,et al.  MiRNA–miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features , 2010, Nucleic acids research.

[64]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[65]  W. Cho.  MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. , 2010, The international journal of biochemistry & cell biology.

[66]  C. Boland,et al.  Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[67]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[68]  Y. Pekarsky,et al.  Reprogramming of miRNA networks in cancer and leukemia. , 2010, Genome research.

[69]  John McAnally,et al.  MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice , 2009, Science.

[70]  Illés J. Farkas,et al.  Human microRNAs co-silence in well-separated groups and have different predicted essentialities , 2009, Bioinform..

[71]  Yi Tie,et al.  miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. , 2009, Cancer letters.

[72]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[73]  F. Slack,et al.  A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. , 2008, Cancer research.

[74]  Carola Berking,et al.  Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer , 2008, Cell cycle.

[75]  Yoshua Bengio,et al.  Classification using discriminative restricted Boltzmann machines , 2008, ICML '08.

[76]  Yuanqing Ye,et al.  Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. , 2008, Cancer research.

[77]  Huan Yang,et al.  MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. , 2008, Cancer research.

[78]  D. Haber,et al.  Dual Role for Argonautes in MicroRNA Processing and Posttranscriptional Regulation of MicroRNA Expression , 2007, Cell.

[79]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[80]  W. Scott,et al.  Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.

[81]  D. N. Watkins,et al.  Lung cancer: Future directions , 2007, Respirology.

[82]  T. Tammela,et al.  MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.

[83]  Geoffrey E. Hinton,et al.  Restricted Boltzmann machines for collaborative filtering , 2007, ICML '07.

[84]  Y. Akao,et al.  MicroRNA-143 and -145 in colon cancer. , 2007, DNA and cell biology.

[85]  James W Jacobson,et al.  MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis. , 2007, Cancer research.

[86]  Michael T. McManus,et al.  Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.

[87]  M. Gould.  CT screening for lung cancer. , 2007, The New England journal of medicine.

[88]  Geoffrey E. Hinton,et al.  Reducing the Dimensionality of Data with Neural Networks , 2006, Science.

[89]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[90]  H. Tagawa,et al.  A microRNA cluster as a target of genomic amplification in malignant lymphoma , 2005, Leukemia.

[91]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[92]  R. Shiekhattar,et al.  TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing , 2005, Nature.

[93]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[94]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[95]  K. Lindblad-Toh,et al.  Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals , 2005, Nature.

[96]  V. Kim,et al.  The Drosha-DGCR8 complex in primary microRNA processing. , 2004, Genes & development.

[97]  Sanghyuk Lee,et al.  MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.

[98]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[99]  F. de Marinis,et al.  Neoadjuvant strategies for non-small cell lung cancer. , 2004, I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.].

[100]  V. Ambros,et al.  Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation , 2004, Genome Biology.

[101]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[102]  Eun-Young Choi,et al.  The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3'UTR. , 2004, Genes & development.

[103]  A. Rougvie,et al.  The Caenorhabditis elegans hunchback-like gene lin-57/hbl-1 controls developmental time and is regulated by microRNAs. , 2003, Developmental cell.

[104]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[105]  W. Travis,et al.  The new World Health Organization classification of lung tumours , 2001, European Respiratory Journal.

[106]  V. Ambros,et al.  An Extensive Class of Small RNAs in Caenorhabditis elegans , 2001, Science.

[107]  T. Tuschl,et al.  Identification of Novel Genes Coding for Small Expressed RNAs , 2001, Science.

[108]  L. Lim,et al.  An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans , 2001, Science.

[109]  B. Reinhart,et al.  The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.

[110]  J. Eyfjörd,et al.  A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes , 1996, Nature Genetics.

[111]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[112]  Mario Acunzo,et al.  MicroRNA and cancer--a brief overview. , 2015, Advances in biological regulation.

[113]  Botao Zhao,et al.  miR-143 inhibits cell proliferation by targeting autophagy-related 2B in non-small cell lung cancer H1299 cells. , 2015, Molecular medicine reports.

[114]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[115]  G. Ying,et al.  Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer. , 2014, International journal of oncology.

[116]  Zheng-sheng Wu,et al.  Prognostic significance of let-7b expression in breast cancer and correlation to its target gene of BSG expression , 2013, Medical Oncology.

[117]  R. Recker,et al.  let-7 MicroRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor α Signaling in Breast Cancer , 2011, Molecular medicine.

[118]  N. Rajewsky,et al.  Deep conservation of microRNA-target relationships and 3'UTR motifs in vertebrates, flies, and nematodes. , 2006, Cold Spring Harbor symposia on quantitative biology.

[119]  N. van Zandwijk.  Neoadjuvant strategies for non-small cell lung cancer. , 2001, Lung Cancer.

[120]  J L Kelsey,et al.  Breast cancer: magnitude of the problem and descriptive epidemiology. , 1993, Epidemiologic reviews.

[121]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.